Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature [PDF]
Frontiers in MedicineIn recent years, continuous intraperitoneal insulin infusion (CIPII) has become a valid therapeutic option to achieve good glycemic control for patients with unstable type 1 diabetes and subcutaneous insulin resistance, mainly due to the absorption of ...
Erika Pedone +12 more
doaj +2 more sources
Practical considerations for using concentrated U200 insulin in automated insulin delivery systems [PDF]
Frontiers in EndocrinologyThe use of automated insulin delivery systems (AID) is standard of care for people with type 1 diabetes. However, the limited capacity of insulin pump cartridges, which can hold 1.6-3.0mL or the equivalent of 160–300 units of U100 insulin, can be a ...
Brynn E. Marks +8 more
doaj +2 more sources
A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus [PDF]
Diabetes & Metabolism Journal, 2022 This study evaluated the safety and efficacy of tubeless patch pump called EOPatch in patients with well-controlled type 1 diabetes mellitus (T1DM). This 4-week, two-center, open-label, single-arm study enrolled 10 adult patients diagnosed with T1DM with
Jiyun Park +7 more
doaj +1 more source
Revista de la Sociedad Argentina de Diabetes, 2021 The exponential increase in the prevalence of diabetes mellitus (DM) throughout the world also includes the increase in people with type 1 diabetes (T1D)1.
Luis Grosembacher
doaj +1 more source
Real-World Analysis of Therapeutic Outcome in Type 1 Diabetes Mellitus at a Tertiary Care Center [PDF]
Diabetes & Metabolism Journal, 2022 Insulin replacement in type 1 diabetes mellitus (T1DM) needs intensified treatment, which can either be performed by multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII).
Antonia Kietaibl +2 more
doaj +1 more source
Transient Neonatal Diabetes Mellitus Managed with Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring [PDF]
Neonatal Medicine, 2021 Neonatal diabetes mellitus can be categorized as transient, permanent, or syndromic, and approximately half of the cases are transient. We present a case involving a term newborn who showed overt progression of transient neonatal diabetes mellitus, with ...
Min Soo Kim +9 more
doaj +1 more source
Insulin pump therapy in transient neonatal diabetes mellitus [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2013 Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia.
Joong Heum Park +6 more
doaj +1 more source
Symposium 16: Clinical follow-up: new guidelines and consensus
Revista de la Sociedad Argentina de Diabetes, 2022 Immune-mediated diabetes in adults is a challenge in its diagnosis, as well as its differentiation from type 2 diabetes and LADA. In the follow-up and treatment of this population, an intensified insulin therapy is the ideal regimen of insulin ...
Susana Apoloni
doaj +1 more source
Coloured Petri Nets-Based Modeling and Validation of Insulin Infusion Pump Systems
Applied Sciences, 2022 Safety and effectiveness are crucial quality attributes for insulin infusion pump systems. Therefore, regulatory agencies require the quality evaluation and approval of such systems before the market to decrease the risk of harm, motivating the usage of ...
Tássio Fernandes Costa +4 more
doaj +1 more source
Вопросы современной педиатрии, 2020 Background. Dermatological complications of insulin therapy in children with type 1 diabetes (T1D) cause low patient retention to treatment, reduce insulin therapy (with injection pens and pumps) efficiency, limit the use of modern high-tech methods of ...
Alisa V. Vitebskaya +2 more
doaj +1 more source